Scientific Publications | SILLAJEN

Scientific Publications

Targeting, Attacking, and Eradicating Cancers®

Scientific Publications

16 cases in total ˙ 2/2 Page

Poster
Preclinical
Clinical

A Phase 1 study of BAL0891 as monotherapy and in combination with chemotherapy in patients with advanced solid tumours

EORTC-AACR-NCI 2023 Poster

NO 6
A Phase I/II Study of Pexa-Vec Oncolytic Virus in Combination with Immune Checkpoint Inhibition in Refractory Colorectal Cancer: An Interim Safety Report

Gastrointestinal Cancers Symposium 2019 Poster

NO 5
A Phase I dose escalation trial evaluating the impact of an in situ Immunization strategy with Intra-Tumoral Injections of Pexa-Vec in combination with ipilimumab in advanced solid tumors with injectable lesions.

ESMO IO 2018 Poster

NO 4
Single intravenous preoperative administration of the oncolytic vaccinia virus Pexa-Vec to prime anti-tumor immunity

ASCO 2018 Poster

NO 3
Combination of oncolytic vaccinia virus and immune checkpoint blockade overcomes resistance to immunotherapy in renal cell carcinoma

AACR 2018 Poster

NO 2
Phase 2 Trial of Pexa-Vec, an Oncolytic and Immunotherapeutic Vaccinia Virus, in Patients with Metastatic, Refractory, Renal Cell Carcinoma (RCC)

GU ASCO 2018 Poster

NO 1